KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Major Shareholder Venrock Healthcare Capital Par Acquires 20,686 Shares

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) major shareholder Venrock Healthcare Capital Par purchased 20,686 shares of the business’s stock in a transaction dated Wednesday, January 24th. The stock was purchased at an average price of $12.44 per share, for a total transaction of $257,333.84. Following the completion of the acquisition, the insider now […]

Leave a Reply

Your email address will not be published.

Previous post Synchrony Financial (NYSE:SYF) Price Target Raised to $46.00 at Stephens
Next post The Travelers Companies, Inc. (NYSE:TRV) SVP Paul E. Munson Sells 2,121 Shares